Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
1 other identifier
interventional
108
1 country
1
Brief Summary
The goal of this clinical trial is to test whether human-centered nursing care lowers emotional distress and improves quality of life for people who are awake during thyroid thermal ablation. The procedure uses local anesthesia, so participants remain awake and may feel tense. Human-centered care focuses on emotional support, clear communication, comfort, and follow-up, and it may improve the experience and recovery for patients. The main questions are: Does human-centered nursing care reduce emotional distress levels in patients undergoing thyroid thermal ablation? Does human-centered nursing care improve patient quality of life after thyroid thermal ablation? If there is a comparison group: Researchers will compare human-centered nursing care to usual nursing care to see if human-centered care leads to lower emotional distress and higher quality of life. Participants will: Receive either human-centered nursing care or usual nursing care. Complete questionnaires before, during, and after the procedure to measure emotional distress, quality of life, pain, and satisfaction with care. Have their vital signs and quality of life tracked during and after the procedure. Have their adherence to care plans and any complications monitored. The main outcomes are emotional distress levels and quality of life. Other outcomes include pain and vital signs during the procedure, satisfaction with care, and complication rates. Results may guide better care for people undergoing small, minimally invasive treatments while awake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 24, 2025
December 1, 2025
7 months
November 29, 2025
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in emotion distress from baseline to post-procedure (HADS)
From enrollment to the end of treatment at 3 months
Change in the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scores from baseline to 3 months
From enrollment to the end of treatment at 3 months
Change in Thyroid Cancer-Specific Quality of Life Questionnaire scores from baseline to 3 months
From enrollment to 3 months after end of treatment
Secondary Outcomes (2)
Intraoperative pain intensity (Visual Analog Scale)
Intraoperative period (during the procedure)
Patient satisfaction with nursing care (Newcastle Satisfaction with Nursing Scale, NSNS)
Postoperative Day 1
Study Arms (2)
Humanistic Continuing Care via WeChat
EXPERIMENTALUsual Care (No Structured WeChat Program)
ACTIVE COMPARATORInterventions
Description: Structured, humanistic peri-operative nursing program delivered through WeChat in addition to routine care. Components: pre-procedure needs assessment and expectation setting; brief coping skills coaching (e.g., paced breathing); intra-procedure step-by-step explanations, reassurance, and comfort measures; post-procedure education, recovery guidance, and psychosocial support; symptom monitoring with red-flag escalation; medication/wound-care and appointment reminders; on-demand messaging during service hours; optional caregiver engagement. Delivery \& Schedule: Nurse-led. One pre-procedure session; intra-procedure support on the day of ablation; post-procedure WeChat check-ins at least weekly plus on-demand messaging for 12 weeks. Fidelity tracked via standardized checklists. Arm(s): Experimental - Humanistic Continuing Care via WeChat.
Participants receive standard peri-operative nursing and institutional discharge materials, including routine pre-procedure counseling, standard intra-procedure monitoring, printed/posted instructions for home care, and follow-up per usual practice (e.g., clinic visit or routine phone call). They may contact the clinic using standard channels as needed, but there is no scheduled, structured WeChat outreach or humanistic continuing-care protocol.
Eligibility Criteria
You may qualify if:
- Age 16-60 years; scheduled for thyroid thermal ablation
- Papillary thyroid carcinoma (PTC)
- Number of target lesions \<= 3
- Largest lesion diameter \<= 2 cm; clinical stage T1N0M0 by imaging
- Awake and able to cooperate under local anesthesia
- Owns a smartphone and can use WeChat
You may not qualify if:
- Serious medical comorbidities or cognitive impairment that precludes participation
- Prior thyroid surgery or thermal ablation
- Unwilling or unable to join the WeChat group or complete postoperative follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ming-an Yulead
Study Sites (1)
China-Japan Friendship Hospital
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Personnel responsible for evaluating the primary or secondary outcome measures remain unaware of the participants' group assignments.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of department of intervention medicine
Study Record Dates
First Submitted
November 29, 2025
First Posted
December 24, 2025
Study Start
December 15, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 24, 2025
Record last verified: 2025-12